Source: BioPortfolio

Ironwood Pharmaceuticals: Ironwood Pharmaceuticals to Present at the 28th Annual Credit Suisse Healthcare Conference

Ironwood Pharmaceuticals Inc. NASDAQ IRWD will present a corporate update at the 28th Annual Credit Suisse Healthcare Conference on Tuesday November 12 2019 at 410 p.m. Mountain Standard Time 610 p.m. Eastern Time at the Phoenician in Scottsdale Arizona.A ...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Ironwood's latest SEC filings

Annual Revenue

Based on data from Ironwood's latest SEC filings

Employees

Mark Mallon's photo - CEO of Ironwood

CEO

Mark Mallon

CEO Approval Rating

88/100

Ironwood is a drug manufacturer that develops and markets medicines for the treatment of irritable bowel syndrome and ch... Read more